Drug Eluting Versus Covered Stent for Femoropopliteal Artery Lesions: Results of the ULTIMATE Study

Recommended standards for reports dealing with lower extremity ischemia: Revised version

Robert B. Rutherford, J.Dennis Baker, Calvin B. Ernst et al. · Journal of Vascular Surgery · 1997 · 3.6K citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +11

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

Victor Aboyans, Jean‐Baptiste Ricco, Marie-Louise Bartelink et al. · European Heart Journal · 2017 · 3.3K citations · Full text

Medicine, Cardiology, Surgery +17

Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia

Martin Björck, J J Earnshaw, Stefan Acosta et al. · European Journal of Vascular and Endovascular Surgery · 2019 · 507 citations · Full text

Medicine, Surgery, Hemodynamic Management +15

A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial

William A. Gray, Koen Keirse, Yoshimitsu Soga et al. · The Lancet · 2018 · 289 citations

Medicine, Cardiology, Surgery +16

Heparin-Bonded Covered Stents Versus Bare-Metal Stents for Complex Femoropopliteal Artery Lesions

Johannes Lämmer, Thomas Zeller, Klaus A. Hausegger et al. · Journal of the American College of Cardiology · 2013 · 283 citations

Medicine, Cardiology, Surgery +11